Literature DB >> 28422394

Homozygous variant in C21orf2 in a case of Jeune syndrome with severe thoracic involvement: Extending the phenotypic spectrum.

Aideen M McInerney-Leo1,2, Lawrie Wheeler1, Mhairi S Marshall1, Lisa K Anderson1, Andreas Zankl3,4, Matthew A Brown1, Paul J Leo1, Carol Wicking5, Emma L Duncan1,6,7,8.   

Abstract

We previously reported exome sequencing in a short-rib thoracic dystrophy (SRTD) cohort, in whom recessive mutations were identified in SRTD-associated genes in 10 of 11 cases. A heterozygous stop mutation in the known SRTD gene WDR60 was identified in the remaining case; no novel candidate gene/s were suggested by homozygous/compound heterozygous analysis. This case was thus considered unsolved. Re-analysis following an analysis pipeline update identified a homozygous mutation in C21orf2 (c.218G > C; p.Arg73Pro). This homozygous variant was previously removed at the quality control stage by the default GATK parameter "in-breeding co-efficient." C21orf2 was recently associated with both Jeune asphyxiating thoracic dystrophy (JATD) and axial spondylometaphyseal dysplasia (axial SMD); this particular mutation was reported in homozygous and compound heterozygous state in both conditions. Our case has phenotypic features of both JATD and axial SMD; and the extent of thoracic involvement appears more severe than in other C21orf2-positive cases. Identification of a homozygous C21orf2 mutation in this case emphasizes the value of exome sequencing for simultaneously screening known genes and identifying novel genes. Additionally, it highlights the importance of re-interrogating data both as novel gene associations are identified and as analysis pipelines are refined. Finally, the severity of thoracic restriction in this case adds to the phenotypic spectrum attributable to C21orf2 mutations.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  C21orf2; Jeune syndrome; ciliopathy; exome sequencing; short-rib polydactyly; spondylometaphyseal dysplasia

Mesh:

Substances:

Year:  2017        PMID: 28422394     DOI: 10.1002/ajmg.a.38215

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies.

Authors:  Wenjuan Zhang; S Paige Taylor; Hayley A Ennis; Kimberly N Forlenza; Ivan Duran; Bing Li; Jorge A Ortiz Sanchez; Lisette Nevarez; Deborah A Nickerson; Michael Bamshad; Ralph S Lachman; Deborah Krakow; Daniel H Cohn
Journal:  Hum Mutat       Date:  2017-11-06       Impact factor: 4.878

2.  Novel KIAA0753 mutations extend the phenotype of skeletal ciliopathies.

Authors:  A Hammarsjö; Z Wang; R Vaz; F Taylan; M Sedghi; K M Girisha; D Chitayat; K Neethukrishna; P Shannon; R Godoy; K Gowrishankar; A Lindstrand; J Nasiri; M Baktashian; P T Newton; L Guo; W Hofmeister; M Pettersson; A S Chagin; G Nishimura; L Yan; N Matsumoto; A Nordgren; N Miyake; G Grigelioniene; S Ikegawa
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

3.  Whole Genome Sequencing Revealed Mutations in Two Independent Genes as the Underlying Cause of Retinal Degeneration in an Ashkenazi Jewish Pedigree.

Authors:  Kevin Gustafson; Jacque L Duncan; Pooja Biswas; Angel Soto-Hermida; Hiroko Matsui; David Jakubosky; John Suk; Amalio Telenti; Kelly A Frazer; Radha Ayyagari
Journal:  Genes (Basel)       Date:  2017-08-24       Impact factor: 4.096

4.  Mutations in GRK2 cause Jeune syndrome by impairing Hedgehog and canonical Wnt signaling.

Authors:  Michaela Bosakova; Sara P Abraham; Alexandru Nita; Eva Hruba; Marcela Buchtova; S Paige Taylor; Ivan Duran; Jorge Martin; Katerina Svozilova; Tomas Barta; Miroslav Varecha; Lukas Balek; Jiri Kohoutek; Tomasz Radaszkiewicz; Ganesh V Pusapati; Vitezslav Bryja; Eric T Rush; Isabelle Thiffault; Deborah A Nickerson; Michael J Bamshad; Rajat Rohatgi; Daniel H Cohn; Deborah Krakow; Pavel Krejci
Journal:  EMBO Mol Med       Date:  2020-10-14       Impact factor: 12.137

5.  High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses.

Authors:  Anna Lindstrand; Giedre Grigelioniene; Anna Hammarsjö; Maria Pettersson; David Chitayat; Atsuhiko Handa; Britt-Marie Anderlid; Marco Bartocci; Donald Basel; Dominyka Batkovskyte; Ana Beleza-Meireles; Peter Conner; Jesper Eisfeldt; Katta M Girisha; Brian Hon-Yin Chung; Eva Horemuzova; Hironobu Hyodo; Liene Korņejeva; Kristina Lagerstedt-Robinson; Angela E Lin; Måns Magnusson; Shahida Moosa; Shalini S Nayak; Daniel Nilsson; Hirofumi Ohashi; Naoko Ohashi-Fukuda; Henrik Stranneheim; Fulya Taylan; Rasa Traberg; Ulrika Voss; Valtteri Wirta; Ann Nordgren; Gen Nishimura
Journal:  J Hum Genet       Date:  2021-04-20       Impact factor: 3.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.